ReviewBreast cancer research : BCR2006
Array-CGH and breast cancer.
Review in Breast cancer research : BCR, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Article
- Article
- Bayesian hierarchical structured variable selection methods with application to MIP studies in breast cancer.Journal of the Royal Statistical Society. Series C, Applied statistics · 2014Article
- Molecular markers for breast cancer: prediction on tumor behavior.Disease markers · 2014Review
- Hereditary breast cancer: clinical, pathological and molecular characteristics.Breast cancer : basic and clinical research · 2014Review
- Article
- Concurrent gene signatures for han chinese breast cancers.PloS one · 2013Article
- Integrated genomic analysis of breast cancers.Balkan journal of medical genetics : BJMG · 2012Article
- A common copy-number breakpoint of ERBB2 amplification in breast cancer colocalizes with a complex block of segmental duplications.Breast cancer research : BCR · 2012Article
- Simultaneous copy number gains of NUPR1 and ERBB2 predicting poor prognosis in early-stage breast cancer.BMC cancer · 2012Article
- Copy number imbalances between screen- and symptom-detected breast cancers and impact on disease-free survival.Cancer prevention research (Philadelphia, Pa.) · 2011Article
- Article
- High-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genes.PloS one · 2011Article
- Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer.PloS one · 2011Article
- Multidisciplinary approach of early breast cancer: the biology applied to radiation oncology.Radiation oncology (London, England) · 2010Review
- CHESS (CgHExpreSS): a comprehensive analysis tool for the analysis of genomic alterations and their effects on the expression profile of the genome.BMC bioinformatics · 2009Article
- Aneuploidy prediction and tumor classification with heterogeneous hidden conditional random fields.Bioinformatics (Oxford, England) · 2009Article
- Robust methods for accurate diagnosis using pan-microbiological oligonucleotide microarrays.BMC bioinformatics · 2009Article
- Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer.BMC cancer · 2008Article
- Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors.BMC genomics · 2008Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The introduction of comparative genomic hybridization (CGH) in 1992 opened new avenues in genomic investigation; in particular, it advanced analysis of solid tumours, including breast cancer, because it obviated the need to culture cells before their chromosomes could be analyzed. The current generation of CGH analysis uses ordered arrays of genomic DNA sequences and is therefore referred to as array-CGH or matrix-CGH. It was introduced in 1998, and further increased the potential of CGH to provide insight into the fundamental processes of chromosomal instability and cancer. This review provides a critical evaluation of the data published on array-CGH and breast cancer, and discusses some of its expected future value and developments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.